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Of dogs and hookworms: man’s best friend
and his parasites as a model for
translational biomedical research
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Abstract: We present evidence that the dog hookworm (Ancylostoma caninum) is underutilised in the study of
host-parasite interactions, particularly as a proxy for the human-hookworm relationship. The inability to passage
hookworms through all life stages in vitro means that adult stage hookworms have to be harvested from the gut
of their definitive hosts for ex vivo research. This makes study of the human-hookworm interface difficult for technical
and ethical reasons. The historical association of humans, dogs and hookworms presents a unique triad of positive
evolutionary pressure to drive the A. caninum-canine interaction to reflect that of the human-hookworm relationship.
Here we discuss A. caninum as a proxy for human hookworm infection and situate this hookworm model within the
current research agenda, including the various ‘omics’ applications and the search for next generation biologics to
treat a plethora of human diseases. Historically, the dog hookworm has been well described on a physiological and
biochemical level, with an increasing understanding of its role as a human zoonosis. With its similarity to human
hookworm, the recent publications of hookworm genomes and other omics databases, as well as the ready availability
of these parasites for ex vivo culture, the dog hookworm presents itself as a valuable tool for discovery and translational
research.
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Background
“His name is not Wild Dog any more, but the First Friend,
because he will be our friend for always and always and
always.” Rudyard Kipling
Over one-third of people on the planet harbour a
parasitic helminth [1, 2]. Helminth infections are
responsible for a host of morbidities that trap people in
a cycle of poverty. Moreover, parasitic diseases kill
millions of people each year, primarily in developing
countries of the tropics [3, 4]. Over 80 percent of
helminth infections are caused by soil transmitted hel-
minths (STH) [5]. Elimination of STH in Western soci-
ety started in the early 20th century as a result of better
sanitation and public sewerage programs [6]. The prob-
lem of helminth infections in developing nations was
recognised, but it was not until the advent of anthelmin-
tic drugs and the World Health Organisation initiatives
of the 1950s that widespread elimination of STH was
attempted [7–10].
As we approached the 21st century, rather than cele-
brating the worldwide demise of STH, drug failures and
incomplete coverage has meant the persistence of this
foe. Previously, effective drugs like mebendazole and
other benzimidazole anthelmintics are now unable to
completely eliminate STH infections [1, 11–18]. Histor-
ical evidence suggests that drugs alone will not result in
the elimination of STH infection and the development
of resistance to benzimidazoles in gastrointestinal nema-
todes of livestock [19–21] is a major point of concern
for human STH infections, due to the reliance on alben-
dazole for human hookworm treatment. Indications are
that other means of control should be at the fore of
research and development agendas [3, 22–24]. Two such
avenues are the identification of new anthelmintic com-
pounds [25, 26] and the development of vaccines that
are effective against STH [3, 27]. Key to this research is
a fundamental understanding of the interactions
between helminths and their environments as well as
the key signals that helminths require from their hosts
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to facilitate their extraordinary parasitic existence [10].
Characterising parasitic helminths at a deep molecular
level will reveal vulnerable pathways that can be
exploited by novel drugs [10, 28], and molecules of im-
mutable vaccine antigen potential [29, 30].
Developing nations are not the only benefactors of
hookworm research. Indeed, in developed countries
there is an increase in the incidence of autoimmune and
allergic diseases that has been linked to lack of exposure
to pathogens such as STH [31]. It is apparent from epi-
demiological studies [32–36] and clinical trials [37, 38]
that the immunomodulatory inputs provided by expos-
ure to STH and other pathogens assist in the develop-
ment and maintenance of a healthy immune system in
humans. Characterising helminth-driven immunoregula-
tion at a molecular level will shed light on the aetiology
of inflammatory diseases, and may uncover important
disease/pathology pathways that can be targeted by
helminth-derived therapeutics [39, 40].
The identification of a suitable model for the study of
such a broad research agenda examining both the bene-
fits of iatrogenic helminth infections and the pathogen-
esis of STH infections needs to be carefully considered.
The benefit is the generation of a large amount of trans-
latable research data coupled with an economy of scien-
tific effort and resources. Fruitful models ideally need to
be naturally occurring (i.e. not a human parasite manip-
ulated to survive in experimental animals) and closely
resemble the relationship between a STH and its human
host. The human-hookworm-dog axis reflects an intim-
ate evolutionary relationship between three organisms, a
triad that presents a naturally selected model for inte-
grated research. The dog hookworm, primarily Ancylos-
toma caninum, is discussed in this context in this
review.
Of humans, hookworms and hounds: the relationship
between humans, hookworms and dogs is enduring and
nuanced
For thousands of years (estimated to be anywhere be-
tween 14,000 and ~35,000 years [41]) humans and ca-
nines have shared the same evolutionary drivers. The
process of domestication has resulted in positive select-
ive pressure on dogs to be more like humans for thou-
sands of generations [42–44]. Genetic evidence suggests
that dogs were domesticated from wolves [45], with suc-
cessive domestication events occurring over at least
33,000 years [41]. Importantly, dogs accompanied
humans over the threshold from hunter gatherers to
agricultural based societies, and this close association
with humans has meant that dogs have evolved to toler-
ate diets rich in starch [46]. Co-habitation between
humans and dogs has resulted in shared nutritional, bac-
terial and pathogenic environments [42, 44, 47], making
dogs a natural animal model for human disease [48].
Figure 1 illustrates the triad relationship of hookworms,
humans and canines. Sharing environments with each
other increases the risk of cross-infection with each
other’s parasites. We know that Strongyloides, Toxocara,
tapeworms and hookworms can be passed from dogs to
humans and bidirectional transfer occurs in some cases,
acting as pools for reinfection.
Dogs as functional models for human disease
The parallel evolution between dog and human may
have driven the predisposition to autoimmune diseases
through antagonistic pleiotropy [41]. Diseases that have
underlying similarities to human disease can be utilised
for the study of aetiology and treatment. Genetic bottle-
necks that have occurred in dog breed conformation
have meant that many dog breeds are good models for
both monogenic and complex genetic human diseases
[48]. For example:
 Nova Scotia duck tolling retrievers develop canine
systemic lupus erythematosus which is homologous
to human systemic lupus erythematous (SLE) [48]
 Osteogenesis imperfecta (brittle bone disease) in
beagles and golden retrievers (polygenic disease) [49,
50]
 A number of dog breeds (Pembroke Welsh corgi,
Boxer, Rhodesian ridgeback, German Shepherd dog,
and Chesapeake Bay retriever) develop canine
degenerative myelopathy, an amyotrophic lateral
sclerosis-like disease that has similar underlying gen-
etic basis in humans (sod1 gene) [51]
 Diseases such as narcolepsy [52], cancers [53, 54]
and obsessive-compulsive disorder [55] that occur in
humans have the same underlying genetic basis in
dogs
Diseases like diabetes that occur in both humans and
dogs and are polygenic with similar underlying single
nucleotide polymorphisms (SNPs) in T helper 2 type cy-
tokines, reflect the complex environmental and genetic
sequelae in the development of this disease [56]. Simi-
larly, dilated cardiomyopathy (DCM) is associated with a
large number of homologous genes in both humans and
canine breeds [57], making these dogs excellent models
for the study of this disease in humans. These parallels
between human and dog diseases mean that canine
models provide identification, diagnostic and therapeutic
research opportunities in a naturally occurring animal
model.
The case of dogs and inflammatory bowel disease
(IBD) is a little more confounding. Dogs with spontan-
eous IBD have similar symptoms and clinical presenta-
tion to humans with the disease [58, 59], yet the
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underlying basis of these diseases has not been identi-
fied. In the case of risk for gluten sensitivity in dogs
there has been no link to the major histocompatibility
complex (MHC) genes [60], as has been found in
humans with celiac disease [61, 62].
Despite the established value of dog-human disease
models, canine models are yet to be fully exploited as
functional models for human hookworm disease. One
exception is the Human Hookworm Vaccine Initiative,
which used the A. caninum-dog model [63] for identify-
ing molecules that could be candidates for human hook-
worm vaccines [3].
Hookworms are a large group of closely related
organisms
In humans, the term “hookworm” is often used to refer
to Necator and Ancylostoma interchangeably even
though there are a number of distinctions as highlighted
in their life-cycles, as described in Fig. 2. These organ-
isms are grouped together on the basis of clinical pres-
entation, the similarity of the organisms (both in
appearance and life-cycle) and their success as parasites
(Table 1). Physically, hookworms can appear similar,
with Necator americanus and Ancylostoma duodenale
ova being difficult to distinguish visually. Phenotypic
similarities can mean that species that have large genetic
separation can appear physically alike, for example Ancy-
lostoma braziliense and Ancylostoma ceylanicum have
identical mouthparts in the adult stage, making it impos-
sible to accurately identify species without genetic tools
[49, 50]. This means previous attributions of pathogen-
esis and distribution limits may be more complex than
assumed, and in some cases flawed [50].
The success of hookworms as parasites hinges on their
ability to be well tolerated and adaptive to their hosts.
Hookworms as gut dwelling parasites gain their nutri-
tion from their hosts in the form of blood [62, 63]. To
do this they attach to and slice through the gut wall
where they feed. Ancylostoma is a voracious feeder, esti-
mated to consume between 0.15–0.23 ml blood/worm/
day, whereas Necator consumes ~0.03 ml blood/worm/
day [64]. The host reacting to injury and the presence of
the parasite attempts to expel the parasite through in-
nate immune responses such as mucus production, in-
creased peristalsis and eosinophilia [65–67]. Despite this,
hookworms are usually well tolerated in a healthy host
[68, 69] because they actively create an area of immune
privilege around the site of their attachment by secreting
a suite of immunomodulatory molecules [39, 70–72].
The hookworm genera Ancylostoma and Necator are
intimately associated with the history of humanity, and
it seems these heirloom parasites have evolved with
Fig. 1 The human-hookworm-dog relationship is defined by a long association. Positive evolutionary pressure on canines has caused them to adapt
to human environments. Hookworms have likely had conflicting immunogenic environments during cross infection events between human and dogs.
In the ~14,000 years of association (conservative estimate) it is theoretically possible to have nearly 73,000 generations of hookworm in this timeframe
Shepherd et al. Parasites & Vectors  (2018) 11:59 Page 3 of 16
humans from our primate ancestors [51, 52]. Such is the
close relationship that hookworm ova have been used in
archaeology to help identify migration routes of humans
[51–53] and supports the intertwined immunomodula-
tory interactions proposed by Rook’s “Old Friends The-
ory” [31]. In a literature survey of Ancylostoma and
related species (Table 1), we identified a number of taxo-
nomically related hookworms. These hookworms occur
across a wide range of hosts with some species capable
of establishing patent infection in dogs, cats, golden
hamsters and humans (as is the case for A. ceylanicum).
The common dog hookworm (A. caninum) is closely re-
lated to the human hookworm species N. americanus
and A. duodenale. Phylogenetic studies highlight the
close relationship between A. caninum, N. americanus
and A. duodenale [54–58]. In addition, the life-cycles of
A. caninum and A. duodenale are very similar [59]: both
have a latent stage, faecal-oral transmission, larval hypo-
biosis and mammary-oral infection. The presence of a
latent stage is important as these organisms have a
predisposition to chemotherapeutic resistance [60] and
are useful for the screening of anthelmintic drugs [61].
The dog hookworm has well-described physiology and
biochemistry which situates it as a translational model
The dog hookworm, A. caninum was described in
1859 by Ercolini, and its physiology, morphology,
biology and epidemiology have been well described,
making it a good candidate as a model for transla-
tional research. Initial studies focussed on the
description, harvesting and optimisation of culture
conditions for physiology experiments. It was deter-
mined that optimal conditions for harvested hook-
worms was a Krebs-Ringer solution with the addition
of 50% dog serum, allowing adult worms to survive
for up to 10 weeks [62]. These hookworms were able
to reproduce and produce viable eggs. The addition
of whole red blood cells did not have any effect on
feeding activity and survival [62], and it was shown
by other investigators that the majority of red blood
cells pass through hookworms intact [63]. It was from
these observations that it was assumed that hook-
worms get the majority of their nutrition from plasma
rather than erythrocytes.
It is recognised that parasites convert their metabolic
processes as they transition from free living to parasitic
life-styles. However, little is known about the host cues
and parasite molecular pathways which govern this
process. Metabolic labelling studies in dog hookworm
have determined that C14-labelled glucose is not
converted to glycogen [63], but is diverted into amino
acid production [64] in a metabolism dominated by
fermentative processes [65, 66]. Exposure of hookworm
L3 to dog sera increases feeding rates [67], and large dif-
fusible solutes (protein fraction) stimulate the consump-
tion of glucose [62]. Cyanide inhibition studies show
that the adult dog hookworm is capable of aerobic me-
tabolism and has a tricarboxylic acid (TCA) cycle that is
able to oxidize both pyruvic and succinic acids [68]. In
addition, NADH respiration is not strongly coupled to
oxidative phosphorylation, with evidence that hook-
worms lack respiratory control [69]. Adult A. caninum
succinoxidase activity does not seem to be tightly
coupled to the synthesis of ATP, and external NADH
oxidation that is not coupled to phosphorylation can
occur. The low ratios of phosphorylation/oxidation may
reflect loosely coupled pathways of respiration or the
existence of two pathways of respiration, one coupled to
Fig. 2 Hookworm life-cycles. Life-cycle a Ova contained in infected
faeces hatch in soil and larvae live freely for up to two moults. Third-
stage larvae (L3) come in contact with skin and penetrate the epider-
mis. Migrating through the lymphatic and circulatory system they end
up in the lung. Larvae mature en route to the upper gastrointestinal
tract via the pharynx and become fifth-stage larvae in the duodenum.
Once attached to the small intestine they feed, become mature to
reproductive capacity and mate. Eggs produced by the female worm
are then shed in faeces. Alternatively, the free-living larvae are capable
of infection through the oral route. These organisms are capable in
some cases of latent stage/hypobiosis and trans-mammary or placental
transmission. Life-cycle b does not include oral transmission. Latent
stage/hypobiosis and alternative transfection routes are not reported in
these organisms
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the esterification of inorganic phosphate and another to
the NADH pathway [69].
Fatty acids produced by A. caninum are major end prod-
ucts of metabolism. Labelling studies have shown that
glucose is metabolised to produce acetate, propionate and
CO2 while the amino acids L-valine and L-leucine are
the precursors of isobutyric acid and isovaleric acid,
respectively [65]. Ancylostoma caninum adult worms con-
sume larger quantities of oxygen than other intestinal nem-
atodes [67]; however, they have been shown to fix CO2 to
produce propionate from amino acids via a CO2 fixation
pathway [65, 67]. Adult hookworms display a slowing or
cessation of metabolic fermentation in the presence of oxy-
gen [65], and the presence of oxygen inhibits anaerobic
Table 1 The members of the Ancylostomatidae family and their hosts have overlapping distributions. Zoonotic disease potential,
distribution and pathogenic significance are described in this table. Life-cycles A and B are described above
Species Definitive host Human
zoonosis
Paratenic
host
Global
incidence
Notes Ref.
Ancylostoma
duodenale
Human – Cat, dog Europe, Africa,
India, China,
Asia, Americas
Life-cycle A
as described
in [59];
hypobiosis;
Wakana disease
in humans
[159–161]
Ancylostoma
caninum
Dog Cutaneous infection,
usually asymptomatic
and arrests in tissues;
adult worm in gut
can cause eosinophilic
enteritis
– Tropical and
subtropical
regions
Life-cycle A;
hypobiosis
[86, 162, 163]
Ancylostoma
ceylanicum
Dog,
cat,
human
– Rodent Asia, India,
Sri Lanka,
Philippines,
Australia
Life-cycle A [151, 164–166]
Ancylostoma
braziliense
Dog,
cat
Cutaneous larva
migrans
Rodent Brazil, Africa,
India,
Sri Lanka,
Indonesia,
Philippines
Life-cycle A [81, 167]
Ancylostoma
pluridentatum
Wild
cats,
jaguar,
leopard
None noted – South and
Central Americas;
thought to be
introduced to
Florida bobcat
populations mid-1950s
Life-cycle A [168, 169]
Ancylostoma
tubaeforme
Cat, lynx Cutaneous larva migrans Rodent Worldwide Life-cycle A [170, 171]
Ancylostoma
kusimaense
Badger None noted Dog Japan Life-cycle A [172]
Ancylostoma
protelesis
Aardwolf Unknown – Africa nd [173]
Ancylostoma
somaliense
Jackal Unknown – Africa nd [173]
Ancylostoma
genettae
Genet
(small
African
carnivore)
Unknown – Africa nd [173]
Necator
americanus
Human,
gorilla
Ground itch – Africa, India,
Asia, China,
Central America
Life-cycle B [174–176]
Necator
gorillae
Gorilla Unknown – Africa nd [176]
Uncinaria
stenocephala
Foxes,
wolves,
coyotes
Cutaneous
larva migrans
Dog, cat,
rodent
Temperate
climates
Life-cycle B [96, 177]
Abbreviation: nd life-cycle is not described in the literature
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glycolysis. The interactions of the end products of hook-
worm metabolism with the host have never been explored.
Similarly, there has been no investigation of the role of sec-
ondary metabolites produced by hookworms and their role
in the host-parasite relationship.
Studies of hookworm transition through developmen-
tal stages have failed to comprehensively identify the
triggers that control the penetration, migration and
maturation in host tissues. Like the human hookworm
A. duodenale [70], A. caninum in dog somatic tissues
can enter hypobiosis, a hibernation-like state often
compared to dauer formation in the free-living nema-
tode Caenorhabditis elegans [71, 72]. Experimental
infection of dogs with hookworms has increased our
understanding of these processes. For example, experi-
mental infection of dogs with A. caninum results in a
greater proportion of parasites proceeding to hypobiosis
in dogs which are immunosuppressed by corticosteroid
treatment, and cessation of treatment results in resump-
tion of parasite development, albeit in a relatively unpre-
dictable manner [61]. The cause of this resumption is
unknown but it implies complex molecular/physiological
interactions between host and parasite through all stages
of development.
The propensity to hypobiosis is a valuable characteristic
of a model because hypobiotic larvae are less susceptible
to anthelmintic drugs [60], presumably due to their ability
to slow their metabolic processes. In vitro studies of A.
caninum show recovery from hypobiosis can be induced
by exposure to muscarinic acetylcholine receptor agonists
and cyclic GMP. This activation process results in a rapid
release of infection-associated proteins [71, 73, 74], which
in part mimics the host-specific signalling events seen in
L3 upon exposure to host serum [74]. Very little is known
about the L3 lung stage of A. caninum or the triggers that
prompt migration and maturation of the L4 as it arrives in
the gastrointestinal tract and reaches sexual maturity in
the small intestine. Recent reports show that A. caninum
in older dogs induces a tolerogenic area around the site of
attachment in the gut [75]. In addition, we know from
proteomic and more targeted studies that A. caninum
produces a number of proteins that putatively interact
with immune cells and can induce anti-inflammatory
responses [76–80] which in turn promotes tolerance
in the host.
Our understanding of A. caninum as a human zoo-
nosis has also changed over time. Initially the zoonosis
was defined by larva migrans where the parasite could
penetrate the epidermis but fails to successfully migrate
and is trapped in the skin and underlying musculature,
leading to localised irritation and pruritus [81–83]. It
has now been shown that A. caninum is able to
complete its migration in humans, with occasional
worms reaching the human gut, although a patent
human infection with A. caninum has yet to be reported.
Studies in mice, a monkey and a cat have shown migra-
tion of the parasite into muscle tissues with little inflam-
matory response [84]. This phenomenon has also been
reported in humans with migration of hookworms to
muscle tissues in an individual with a large cutaneous
exposure [85]. In 1994, Croese [86] described numerous
cases where solitary A. caninum were identified in the
human gut by endoscopy, discovered during clinical in-
vestigation for eosinophilic gastroenteritis [87]. These
observations indicate that A. caninum could be a suit-
able proxy for human-hookworm interactions, and much
can be learned about human hookworm infection by
studying A. caninum in its natural dog host.
Omics can provide useful information but must be
augmented with information from animal models
Omics is the collective term for the characterisation of
an organism at the genome, transcriptome, proteome
and metabolome levels. Increasingly, omics have been
used to guide research in host-parasite biology and ther-
apeutics discovery. This approach has been used in the
case of parasitic trematodes to identify the mechanisms
of drug resistance and to identify novel drug targets [88].
Metagenomics and metabolomics are the newest and
most rapidly advancing ‘omics’ technologies, and offer
under-utilised promise for understanding the molecular
basis of host-helminth interactions, particularly metabol-
ism, pharmacotherapeutic action [89] and the presence
and function of commensal microbes. The limitation of
comparative omics is that often there are no homologs
or orthologs of helminth molecules (particularly pro-
teins) in other organisms to assign putative function,
and many of the metabolites are of unknown origin and
function. For example, there are over 700 transcripts in
the A. caninum transcriptome encoding for proteins
with secretory signal peptides with no function assigned
[90]. Unannotated genes in parasites are of interest due
to their likely role in governing a parasitic existence [91].
To augment omics databases to allow for meaningful
bioinformatics analyses, animal models provide invalu-
able information. These models provide important bio-
activity information that cannot be inferred by
bioinformatics alone [39].
We have assembled the currently available omics in-
formation for the family Ancylostomatidae in Table 2,
and have included for comparison the free-living model
nematode C. elegans and the filarial nematode Brugia
malayi. By using comparative tools it was possible using
these databases to identify genes putatively associated
with parasitism by comparing the different transcrip-
tome patterns of the three helminth species [90]. Mining
of assembled proteomic databases can help to identify
proteins, but often the target protein is of unknown. For
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example, using a shotgun proteomics approach Mul-
venna et al. [76] identified 105 A. caninum ES proteins
increased recently to 315 putative proteins in our labora-
tory [92]. Based on gene ontology alone many of these
are putative or of unknown function [76, 92].
Current databases for helminth omics, particularly
hookworm, are incomplete. Only N. americanus has a
published genome [93], and only A. caninum has a com-
prehensive secreted proteome from the adult worm [76],
although the somatic adult worm proteome has been re-
ported from N. americanus [93]. The plasticity and
adaptability of hookworms further accentuates the def-
icit in bioinformatics data. Significant subpopulation
variation of A. caninum has been observed [94], and it
has been speculated that this variation may indicate spe-
ciation events. In addition, these subpopulations could
reflect differences in infectivity for A. caninum [95]. The
analysis of restriction fragment length polymorphisms
(RFLP) of helminths from India and Vietnam supports
the observed phylogenetic relationships but also identi-
fies unclassified Ancylostoma species [96, 97]. This pat-
tern is also observed with N. americanus [98, 99]. The
source of hookworm material used to generate different
omics databases is usually restricted to small popula-
tions, often passaged through unnatural hosts, and dif-
ferent populations are frequently used to compile
different datasets (see Table 2). In conjunction with the
known plasticity of hookworm species, these factors may
diminish valid comparisons across databases. By using in
silico techniques it is possible to use comparative bio-
informatics to combine proteomic and transcriptomic
databases to determine metabolic pathways [100].
Combining omics data with functional data from ani-
mal models is a very powerful tool to identify critical
physiologic and metabolic pathways. Helminth genomes
are often poorly annotated, which can result in missed
identifications of novel pathways in parasites. For
example, it is only from metabolic labelling of metabolic
intermediates of the Leishmania parasite promastigotes
that it was possible to show that the parasite pooled res-
ervoirs of essential molecules for the TCA cycle through
the fermentation of succinate [28]. This is a novel path-
way that could potentially be used as a target for anti-
parasitic drugs and provides an understanding of how
parasites cope with changes in their environment. The
metabolome of Entamoeba during encystation shows the
presence of polyamines [101], an unexpected finding
given that the enzymes responsible for polyamine bio-
synthesis are not annotated in the genome [102]. Eicosa-
noids in helminths are likely produced by novel
pathways, as bioinformatics searches for the genes en-
coding homologues of the mammalian enzymes in this
biosynthesis pathway have not been identified [103].
Given these examples, and the adaptability of the hook-
worm and its phenotypic plasticity, metabolomics profil-
ing is likely necessary to uncover novel pathways and
molecules used by these parasites [104].
Animal models of hookworm interaction
One of the major issues with the study of hookworms is
the inability to culture these parasites through all devel-
opmental stages of their life-cycle in vitro. To this end,
animal models are employed. The ideal model for hu-
man hookworm infection should reflect the pathophysi-
ology of the helminth-host interaction and be
experimentally accessible. Current models all have limi-
tations and many animal experiments are considered
"under-powered" [105] due to the ethical restrictions on
animal experimentation numbers. A further restriction
on models is the availability of immunological reagents
for particular species. Reagents are readily available
for humans, mice/rats, and to a lesser extent dogs
and hamsters, but are more restricted for cats, which
only have a limited palette of immune reagents.
Table 2 The current omics status for the Ancylostomatidae, the free-living model nematode Caenorhabditis elegans, and the filarial
nematode Brugia malayi. Genome and transcriptome progress for Ancylostomatidae can be monitored on the Gold-genome online
database (https://gold.jgi.doe.gov/distributiondata?domain=EUKARYAL&rank=family&group=Ancylostomatidae.). Transcriptome,
proteome and metabolome database updates can also be monitored on (http://www.genome.jp/kegg/kegg1.html) and Wormbase;
(www.wormbase.org)
Organism Genome Transcriptome Proteome/
secretome
Metabolome Reference
C. elegans × × × × [178–187]
N. americanus × × × − [93, 130, 132, 188–192]
A. duodenale − − − − −
A. caninum ×a × × − [76, 90, 92, 188, 193–195]
A. ceylanicum × × − − [193, 196]
A. braziliense − × − - [197]
Brugia malayi × × × − [9, 90, 198–203]
aData collection still in process
Key: ×, omics data available; −, omics data not available
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Moreover, human hookworms do not generally reach
maturity in mice or rats [106, 107], precluding func-
tional studies using genetically modified hosts.
There are three main experimental animal models
commonly used as a proxy for gastrointestinal (GI)
nematode infections of humans; mice/rat, hamsters and
dogs as summarised in Table 3. There have been at-
tempts to establish hookworm-primate models using
marmots [108] however these models have been con-
stricted by experimental cost [109]. The two benchmark
murine models used for STH infection discussed in this
review are Heligmosomoides polygyrus bakeri and Nip-
postrongylus brasiliensis. Trichuris muris is homologous
to the human whipworm Trichuris trichiura, and while
it is a STH it is not within the scope of this review. The
rat is the natural host of N. brasiliensis and is considered
a good model for human hookworm infection, particu-
larly due to the similarities between the N. brasiliensis
and N. americanus secretomes [110]. However, there are
some features of the N. brasiliensis life-cycle in rodents
that are dissimilar to human hookworm infections,
particularly the rapid transit time from percutaneous in-
fection to reaching the gut, as noted below. Nippostron-
gylus brasiliensis is not a natural parasite of mice,
although it can complete its life-cycle in them.
While N. brasiliensis is less closely related phylogenetic-
ally to human hookworms than are other Ancylostoma
spp., it is often used to study the pathophysiology and im-
munology of STH infection. One of the major differences
between human hookworm infection and N. brasiliensis
infection in mice is the self-cure phenomenon that occurs.
Within two weeks of infection, mice expel the parasite
and develop protective immunity that is dependent on
CD4+ Th2 cells. Indeed, this model has been used to study
the development of host protective immunity and the in
vivo regulation of Th2 responses in general [111–113].
One of the advantages of this model is the minimal inter-
animal variation, however, its life-cycle is abbreviated and
is not characterised by the chronicity of human hook-
worm infection.
As a natural parasite of mice, H. polygyrus is often
chosen to study the pathophysiology and the immun-
ology of intestinal nematode infections [111, 114, 115].
While taxonomically related to human hookworms, H.
polygyrus differs from human hookworms in that it has
a much simpler life-cycle. Heligmosomoides polygyrus
does not have a lung stage and exhibits an enteric life-
cycle with a faecal-oral infection route. However, like
human hookworm infection, H. polygyrus establishes a
chronic infection in its definitive host. As such, this
Table 3 The major animal models used to study human hookworm infection
Animal model Naturally
occurring
host-parasite
Similar life-cycle
cf. Necator/
Ancylostoma
spp. in humans
Infection
model
Model used
to study
Regulatory
restrictions
Reference
Mouse (Mus musculus)
Heligmosomoides
polygyrus bakeri
Yes No (no lung
stage)
Chronic
helminthiasis
Pathophysiology of
infection, immunological
studies, vaccinomics
– [114, 115, 204–208]
Nippostrongylus
brasiliensis
No Yes Rapid
expulsion
Immunology of
helminth infection,
pathophysiology
of infection
– [110, 207, 209–212]
Golden Syrian
hamster (M. auratus)
Ancylostoma
ceylanicum
No No (infection
by oral gavage)
Rapid
expulsion
Vaccinomics,
anti-helminthics
Hamsters not
permitted in
some countries
(e.g. Australia)
[123, 213, 214]
Necator americanus No Yes Chronic
helminthiasis
Pathophysiology
of infection,
immunological
studies, vaccinomics
Hamsters not
permitted in
some countries.
Ova transport
restricted in US
[121, 215, 216]
Beaglea (Canis
lupus familiaris)
Ancylostoma
caninum
Yes Yes including
hypobiosis
Acute and
chronic
helminthiasis
Pathophysiology
of infection,
immunological
studies, vaccinomics
Ethical considerations [144]
aAlternative sources of A. caninum can be from naturally infected dogs in endemic areas
Shepherd et al. Parasites & Vectors  (2018) 11:59 Page 8 of 16
model has been used to extensively characterise the
Th2-skewing and immunoregulatory properties of GI
nematodes [116], and ultimately resulted in the intro-
duction of the term “modified Th2 response” [117].
The mouse models of N. brasiliensis and H. polygyrus
have been used to decipher the innate and adaptive im-
mune responses responsible for worm expulsion and the
development of chronicity [118]. Both parasites drive a
modified Th2 response typified by IL-4, IL-5, IL-9, IL-13
and IL-10 which mediates eosinophilia, mucosal changes
such as mast cell hyperplasia, mucus production and
IgG1 and IgE production [119].
One of the most important breakthroughs in the
development of animal models for human hookworm in-
fection was the establishment of patent infections in
golden Syrian hamsters (Mesocricetus auratus) with N.
americanus and A. ceylanicum. Both models however
are “labours of love” and require considerable time to
establish because they generally rely on immunosuppres-
sion with steroids, at least in the early phases of model
establishment [120–122]. Immunosuppression with ste-
roids of the golden Syrian hamster allows A. ceylanicum
and N. americanus infections to reach patency [121,
123], thereby providing material for laboratory analyses
including genomic, transcriptomic and metabolomics
studies. The A. ceylanicum-hamster model [124] has
been utilized for testing vaccine efficacy, understanding
mechanisms of adaptive immunity, and testing of anthel-
minthic drugs, often as a model for human infection
with N. americanus [106, 125]. These interpretations
have been supported by observations in small scale stud-
ies in humans [126–128].
The N. americanus-hamster model was first estab-
lished by Sen & Seth in 1970 [129], and tailored as a
model for testing drugs and vaccines by Jian et al. in
2003 [121]. Importantly, the in vivo generation of adult-
stage N. americanus enabled the sequencing of the adult
worm transcriptome [130], and ultimately contributed
material to the sequencing of the genome in 2014 [93].
It should be noted that N. americanus was adapted to
hamsters through 100 generations of selective pressure.
The ability of a complex multicellular pathogen to adapt
to a new host within 100 generations reflects a high evo-
lutionary rate also observed in A. caninum and reflected
by high DNA polymorphism [90]. We currently do not
understand the molecular basis of the adaptation of N.
americanus to the golden hamster. A comparative ana-
lysis of mitochondrial cytochrome oxidase from N.
americanus obtained from hamsters and natural human
infections suggests a severe genetic bottleneck in
hamster-adapted N. americanus which may limit the
utility of this model [131]. To date, there has been no in-
vestigation of the differences in genomes between N.
americanus sourced from hamsters and those from the
native human host. The ‘omics’ information garnered
from such a comparison would be useful to highlight
those genes related to host adaption and could also en-
hance our understanding of the metabolites produced by
a system in response to changes in the host and an en-
vironmental stimulus.
There are a number of caveats to consider in the ham-
ster model of human hookworm infection. Interpretation
of data generated in the N. americanus-adapted hamster
model may be misleading when applied to human hook-
worm host-parasite biology due to the undefined
changes discussed above. In addition, the model using
immunosuppressed hamsters and N. americanus is still
employed [132, 133], so care should be taken when
interpreting results and drawing parallels between the
two models. Another problem with the hamster model
of N. americanus infection is its restricted geographic
use; for example, hamsters are a prohibited laboratory
species in Australia due to strict quarantine restrictions
[134]. This limits its ability to be used in comparative
and translatable studies universally. Logistically, the
hamster is a small animal so the parasite load that the
animal can tolerate is low when compared to a human
or larger animal such as a dog. Moreover, adult N. amer-
icanus do not reach full size in hamsters [121], even
though they do become fecund and infections are pa-
tent. A further weakness of this model is that the small
numbers of adult parasites that can be supported in
hamsters are rapidly expelled compared to the chronicity
that develops in human infection [135].
The canine-hookworm model
The gut-dwelling, blood-feeding stage of A. caninum is
well described at biochemical, transcriptomic and im-
munological levels as discussed here. The excretory/
secretory (ES) component of A. caninum (AcES) at the
host-parasite interface has been described, with over 100
proteins identified in 2009 [76], many of which were as-
cribed to either feeding [136–138] or putatively evading
the host and inducing tolerance [75, 78]. The immuno-
modulatory nature of AcES has been demonstrated [77,
139] with an increasing interest in translational applica-
tions for components from AcES [80, 136, 140–142]. In
addition, possible mechanisms of resistance [15] and
hypobiosis [84] have been studied in this model. The
availability of such an accessible and defined model is at-
tractive for a gamut of research agendas.
A major advantage of the A. caninum-dog relationship
as a model for human hookworm infection is that it is
naturally occurring, and moreover, A. caninum and A.
duodenale are very similar morphologically and genetic-
ally. Due to the larger size of the animal, dogs are more
suitable for recovering larger quantities of adult hook-
worms for laboratory studies. From an individual dog it
Shepherd et al. Parasites & Vectors  (2018) 11:59 Page 9 of 16
may be possible to recover thousands of adult worms,
allowing for comprehensive studies to occur from a sin-
gle collection. One of the major objections to the use of
dogs as animal models however is the ethical concern
around their experimental use; this, combined with the
expense of keeping such a large animal for research pur-
poses, often limits the use of the A. caninum-canine
model. Attempts have been made to create an A. duode-
nale-dog model for research purposes. Using immuno-
suppression with prednisolone it was possible to achieve
patency within six generations of beagle [143]. In later
experiments A. duodenale was maintained in laboratory-
raised beagles for 30 generations using decreasing
amounts of prednisolone, and adaption to the dog was
presumed due to observed decreases in the prepatent
period for the parasite, however a fully permissive model
was not achieved due to the prohibitive resource de-
mands of the project [144]. This is a common theme
with large animal models.
Puppies usually harbour the heaviest burdens of A.
caninum, and worm numbers (or at least eggs in the fae-
ces) tend to diminish over time. An efficacious hook-
worm vaccine based on irradiated parasites was
developed for dogs but was discontinued soon after
reaching the market due to its poor shelf life and low
uptake by pet owners [145, 146]. The dog hookworm
vaccine was based on radiation-attenuated L3 [146], and
although the protective antigenic components were not
identified, two immunodominant L3 secreted antigens
were described from dogs that received the vaccine
[147]. Understanding the mechanisms by which vaccine-
induced immunity to the dog hookworm develops could
inform efforts to develop a subunit human hookworm
vaccine. Such studies have guided antigen discovery for
human hookworm vaccines [148], and even underpin
proposed human trials with irradiated N. americanus L3
(AL, unpublished).
It is our experience that the dog-hookworm model can
be very fruitful when A. caninum is sourced from areas
where dogs are naturally infected, have not received re-
cent anthelmintic therapy, and dogs are excess to re-
quirements. These unwanted animals can result from
wild dog eradication programmes, the culling of rural/
remote camp or village dogs, or the sourcing of stray or
unwanted dogs from residential communities in tropical
and sub-tropical environments. The benefit of this ap-
proach is three-fold: (i) ethically, these animals are not
experimentally infected or euthanized for research pur-
poses, so ethical concerns on their use are minimised;
(ii) international partnerships between developed and
developing countries to source these hookworms means
that educational/research facilities can be meaningfully
engaged in STH research; and (iii) harvesting of animals
from diverse geographical areas gives power to
observations as it reflects natural host-parasite interac-
tions and natural spatio-temporal variation.
The opportunity for international partnering is empha-
sised in the modern research agenda as it aids capacity
building in developing countries [149] that are most af-
fected by STH. It enables the development of collabora-
tive long-term partnerships and stewardship over
research agendas. This is particularly important in the
case of human hookworm research as there are direct
benefits to both developed and developing nations in
terms of vaccine and drug development [150], as well as
development of novel helminth-derived anti-
inflammatory therapeutics [80]. Additionally, partnering
provides the ability to extend research capabilities in a
time of increasing economic rationalisation and com-
petitive grant processes. The inclusion of a broad base of
expertise from immunology, parasitology, veterinary and
agricultural sciences, public health and medicine is pos-
sible in these partnerships and is often aligned with
current integrated approaches to research programs.
Ancylostoma ceylanicum as a model for human
hookworms
Ancylostoma ceylanicum is one of the most indiscrim-
inate hookworms, with the ability to naturally infect
dogs, cats, humans and other animals. It is a domin-
ant hookworm in Asia and present throughout
Australasia [151, 152], and a permissive model in
hamsters is available. To date, models utilising ham-
sters and mice infected with A. ceylanicum have been
used to study pathogenesis [123]. This hookworm
has the potential to be valuable in comparative
‘omics’ studies. For example, using transcriptomics
approaches, putative anthelmintic drug targets were
identified [153]. Comparing the transcriptomes of
adult A. ceylanicum hookworms isolated from feline,
canine and other animal infections has the potential
to identify molecules that are responsible for the
promiscuity in host preference for this parasite. Like
in A. caninum infection, dogs infected with A. ceyla-
nicum develop functional immunity to the parasite
[154]. The advantage of A. ceylanicum as a model
parasite is that it regularly reaches patency in both
humans and dogs [151, 155].
Ancylostoma ceylanicum is closely related to both A.
duodenale and A. caninum [55, 156], so the molecular
mechanisms by which they regulate and skew the host’s
immune pathways are likely to be shared between spe-
cies. However, observations of other parasites show there
are a wide number of adaptions to the parasitic life-style
[157]. For example, there are classes of parasite proteins
that have been implicated in host-parasite interactions
with many having pleiotropic actions [39, 157, 158]. A
comparative study of A. ceylanicum, A. caninum and A.
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duodenale may reveal unique adaptions for each of these
closely related species.
Phenotypically, A. ceylanicum and A. brasiliensis can
be easily confused, making it necessary to augment col-
lection of parasites from natural infections with molecu-
lar characterisation [96, 151]. This complicates acquiring
hookworms from naturally infected dogs where the dis-
tribution of these hookworms overlaps. The secretome
has yet to be defined at the protein level for N. ameri-
canus, A. duodenale or A. ceylanicum, limiting the abil-
ity to make confident assumptions about sequence
conservation of secreted proteins between these species.
It is for these reasons that A. ceylanicum is a more lim-
ited model hookworm.
Conclusions
In the context of human hookworm research, the
human-hookworm-dog axis provides one of the most
unique experimental opportunities for the identification
of bioactive molecules for development of novel immu-
notherapeutics, subunit vaccines, and selection of drug
targets. Domestication has meant that the unique evolu-
tionary relationships between dogs and humans can be
exploited as natural models for human diseases, notably
from our perspective, the parasitic helminth infections
of humans. Positive selection pressure and breed con-
formation has led to genetic restriction in canines, and
has meant that many diseases have the same underlying
genetic basis in dogs and humans. It is likely that
humans and dogs have shared parasites for millennia,
making them an ideal model for the study of host-
parasite biology. Laboratory evidence shows that with
the administration of immunosuppressive therapy it is
possible to achieve patency of hookworm infections in a
variety of unnatural definitive hosts. There are a number
of available models for human hookworm infection;
however, all of these models have limitations. Mouse
models are universally available yet suffer from a range
of dissimilarities to the natural human hookworm infec-
tions. Hamster models have an advantage over mouse
models in that they are permissive for the human hook-
worms N. americanus and A. ceylanicum, but resistance
to infection develops rapidly, unlike human hookworm
infections. Ancylostoma caninum in the dog is a robust,
naturally occurring relationship, and parasites isolated
from animals in endemic areas have the potential to pro-
vide powerful molecular information that is unavailable
from other sources, and reflects naturally occurring in-
teractions. The use of experimentally infected large ani-
mal models for such studies is fraught with ethical
considerations and high economic costs. The study of
natural interactions has the potential to provide more
powerful observations than those of current laboratory
models. Sourcing naturally infected animals provides an
opportunity for international partnering and an opportun-
ity for a diverse portfolio of translatable research out-
comes. It negates many of the ethical and cost concerns
rightly expressed over the housing of large mammals. By
using a strong model for sourcing parasite material it is
possible to make reliable and translatable observations
about hookworm host-parasite biology as well as facilitat-
ing programs focused on development of new control
strategies aimed at eliminating, or at least mitigating,
hookworm infection.
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